HomeInsightsMarket Capitalization

Market Capitalization of Kabra Drugs Ltd

Market Capitalization of Kabra Drugs Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 9, 2024)

stocks purchased

2.4 K

Stocks Traded

(Dec 9, 2024)

Last Updated on: Dec 11, 2024

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

Market Cap

₹ 9.67 crore

Last updated on: Dec 09, 2024

Key Highlights

  • The Market Cap of Kabra Drugs Ltd is ₹ 9.67 crore as of 09 Dec 24 .
  • The Market Cap of Kabra Drugs Ltd changed from ₹ 0.25 crore on March 2019 to ₹ 3.16 crore on March 2024 . This represents a CAGR of 52.62% over 6 years.
  • The Latest Trading Price of Kabra Drugs Ltd is ₹ 9.59 as of 09 Dec 15:30 .

Historical Market Cap of Kabra Drugs Ltd

No data available

* All values are in crore

Company Fundamentals for Kabra Drugs Ltd

No data available

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

Share Price

₹ 9.59

0.00 (0.00%)

stock direction

Last updated on: Dec 09, 2024

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 Dec 20249.59
02 Dec 20249.59
25 Nov 20249.59
18 Nov 20249.59
11 Nov 20249.59
04 Nov 20249.14
28 Oct 20249.14
21 Oct 20249.14
14 Oct 20249.14
07 Oct 20249.14

BlinkX Score for Kabra Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Kabra Drugs Ltd

No data available

No data available

Historical P/E Ratio of Kabra Drugs Ltd

No data available

* All values are in %

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Kabra Drugs Ltd

  • Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989.
  • The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
  • The commercial production commenced in 1991.
  • Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel.
  • In India there are very few manufacturers who are manufacturing the said products.

Kabra Drugs Ltd News Hub

News

Kabra Drugs to conduct EGM

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be ...

Read more

05 Dec 2024 17:27

News

Kabra Drugs schedules board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 December 202...

Read more

26 Nov 2024 09:56

News

Kabra Drugs to convene board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 November 20...

Read more

08 Nov 2024 12:27

News

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 202...

Read more

22 Oct 2024 11:01

News

Kabra Drugs to hold AGM

Kabra Drugs announced that the 35th Annual General Meeting (AGM) of the company will be he...

Read more

16 Sep 2024 09:56

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 20...

Read more

28 Aug 2024 14:54

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Kabra Drugs Ltd Market Cap

What is the market cap of Kabra Drugs Ltd?

As of December 11, 2024, Kabra Drugs Ltd has a market capitalization of ₹9.67, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Kabra Drugs Ltd's market capitalization?

Kabra Drugs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Kabra Drugs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Kabra Drugs Ltd's market capitalization change?

Kabra Drugs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions